Healthcare Sector Attracts Investor Interest Amid Market Uncertainty Uganda Ebola Outbreak Escalates 177 Dead Three New Cases and One American Infected Markets Adjust Expectations for Fed Rate Hike After Inflation Data Surprises IndoStar Capital Reports 130 Crore Annual Profit but Q4 Loss Widens on Security Receipt Provisions Prime Minister Starmer Urges TNT Sports to Make Champions League Final FreetoAir Hindalco Expects Strong FY26 Performance Novelis Turnaround Anticipated by FY27 MD Satish Pai SNDL Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue Uncertainty JBS Q1 2026 Earnings EPS Misses Estimates Stock Declines Interactive Brokers Group Inc IBKR Q1 2026 Earnings EPS Falls Slightly Short of Estimates Amid Stable Trading Activity PRSU Q1 2026 Earnings EPS Beat Provides Bright Spot in Seasonal Quarter JILL Q1 2026 Earnings EPS Beats Estimates Despite Loss Stock Rises Greene County Bancorp Inc GCBC Q2 2025 Earnings Steady Profitability Amid Stable Banking Environment WEBTOON Entertainment WBTN Slides 14 as Stock Navigates Key Support Levels Brighthouse Financial Preferred Stock BHFAO Edges Higher as Support Holds New Providence Acquisition Corp III Warrants NPACW Edges Higher as Warrants Test Key Resistance Empire Petroleum EP Surges Over 12 as Energy Sector Momentum Builds Aytu BioPharma AYTU Holds Near Support Amid LowVolume Trading Oculis Holding OCS Slips 487 as Shares Test Key Support Zone RiverNorth Municipal Income Fund RMM Slightly Eases Amid Tight Trading Range Old National Bancorp Preferred Shares ONBPP Hold Steady Slight Dip Amid Stable Trading Marwynn Holdings MWYN Holds Steady Near 088 as Traders Eye Key Support and Resistance Levels Harvard Ave Acquisition Corp Unit HAVAU Holds Steady Near Trust Value With No Price Movement Seer Inc SEER Edges Higher as Biotech Stock Tests Key Resistance Geopolitical Developments US and Iran Nearing Ceasefire Extension with Strait of Hormuz Reopening MGM Q1 2026 Earnings EPS Miss Triggers Cautious Optimism as Shares Advance Fate Therapeutics Surges Over 10 as Biotech Sector Shows Signs of Life FATE